Company overview
Basic information
Company name
Amberwell, UAB
Company code
302872865
VAT code
LT100013968818
Registered address
Vilnius, Birželio 23-iosios g. 4-16, LT-03204
Registration date
2012-09-26
Company age: 14 y.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.amberballet.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB Amberwell
Company code: 302872865
Address: Vilnius, Birželio 23-iosios g. 4-16, LT-03204
VAT code: LT100013968818
Download a detailed company report
Make confident decisions with all the information about Amberwell, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Amberwell, UAB (company code 302872865) is an operational private limited liability company registered in 2012. The company is classified as a private, micro-sized national private non-financial company with a CEO-only governance structure and private ownership. Its share capital is EUR 2.9K. Amberwell is based in Vilnius, at Birželio 23-iosios g. 4-16, in Vilniaus m. municipality, Vilniaus apskr. county. Its core activity is EVRK code G.47.73.00, retail sale of pharmaceutical products.
Financially, the company increased revenue to EUR 90.8K in 2025 from EUR 77.6K in 2024 and EUR 28.2K in 2023. Net profit improved to EUR 3.4K in 2025, after EUR 68 in 2024 and EUR 921 in 2023, with a 3.8% profit margin in 2025. At the end of 2025, equity stood at EUR 9.2K, assets at EUR 16.5K and liabilities at EUR 7.3K. The equity ratio was 55.6%.
The company reported an average of 1 employee in 2023, 2024 and 2025, and 1 employee so far in 2026.
Financially, the company increased revenue to EUR 90.8K in 2025 from EUR 77.6K in 2024 and EUR 28.2K in 2023. Net profit improved to EUR 3.4K in 2025, after EUR 68 in 2024 and EUR 921 in 2023, with a 3.8% profit margin in 2025. At the end of 2025, equity stood at EUR 9.2K, assets at EUR 16.5K and liabilities at EUR 7.3K. The equity ratio was 55.6%.
The company reported an average of 1 employee in 2023, 2024 and 2025, and 1 employee so far in 2026.